DJIA 17,660.60 -22.98 -0.13%
NASDAQ 4,963.64 -28.30 -0.57%
S&P 500 2,067.21 -1.55 -0.07%
market minute promo

Isis Pharmaceuticals (NASDAQ: ISIS)

54.74 -0.69 (-1.24%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ISIS $54.74 -1.24%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $55.57
Previous Close $55.43
Daily Range $53.56 - $55.96
52-Week Range $27.37 - $77.80
Market Cap $6.6B
P/E Ratio -277.15
Dividend (Yield) $0.00 (0.0%)
Volume 1,593,884
Average Daily Volume 2,545,831
Current FY EPS -$0.26




Drug Makers

Isis Pharmaceuticals (ISIS) Description

The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases. Website:

News & Commentary Rss Feed

3 Biotech Stocks to Buy As the Greek Tragedy Unfolds

Exelixis, Enanta Pharmaceuticals, and Isis Pharmaceuticals are three names in biotech I'm closely watching in case they fall as a result of the financial crisis in Greece.

Sector's Smaller Players Show The Way

Strong Upward Pre-Market Activity For ISIS Pharmaceuticals (ISIS)

Should Isis Pharmaceuticals (ISIS) Be On Your Radar Now? - Tale of the Tape

Isis Pharmaceuticals Inc. Investors Can Finally Sense a Bright Future

After decades of zero return, Isis Pharmaceuticals' stock has been on fire recently. Is it smart to jump on board now?

Commit To Purchase Isis Pharmaceuticals At $33, Earn 9.1% Using Options

Isis Pharmaceuticals Up on Spinal Muscular Atrophy Data - Analyst Blog

ISIS Pharma Still Undervalued, Needham Says

IWM, CRBN: Big ETF Inflows

Health Care Sector Update for 06/22/2015: PFE, ISIS, KPTI

See More ISIS News...

ISIS's Top Competitors

ISIS $54.74 (-1.24%)
Current stock: ISIS
AMGN $154.51 (0.01%)
Current stock: AMGN
GILD $114.45 (-1.05%)
Current stock: GILD
BIIB $406.65 (0.50%)
Current stock: BIIB